Searchable abstracts of presentations at key conferences in endocrinology

ea0090p29 | Calcium and Bone | ECE2023

TransCon PTH Improves Health-Related Quality of Life and Reduces Work Limitations in Adults With Hypoparathyroidism: Patient-Reported Outcomes in the Phase 3 PaTHway Trial

Palermo Andrea , Khan Aliya , Rubin Mishaela , Schwarz Peter , Shoback Dolores M. , Gagnon Claudia , Cetani Filomena , Clarke Bart L. , Tsourdi Elena , Kohlmeier Lynn , Sikjaer Tanja , M Kaiser Stephanie , Lai Bryant , Le John , Ukena Jenny , Sibley Christopher , Shu Aimee , An Xubei , Noori Wahidullah , Smith Alden , Vokes Tamara J.

Background: Individuals with hypoparathyroidism often experience a range of symptoms associated with reduced health-related quality of life (HRQoL) and work productivity. Conventional therapy aims to alleviate hypocalcemia and acute symptoms but fails to restore normal parathyroid hormone (PTH) physiology or improve HRQoL. In the PaTHway trial, 79% of participants treated with TransCon PTH vs. 5% placebo (P<0.0001) met the primary efficacy endpoint (normal serum c...

ea0099oc2.2 | Oral Communications 2: Calcium and Bone | Part I | ECE2024

Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway trial

Schwarz Peter , Rejnmark Lars , Gosmanova Elvira , Khan Aliya , Makita Noriko , Imanishi Yasuo , Takeuchi Yasuhiro , Sprague Stuart , Shoback Dolores M. , Kohlmeier Lynn , Rubin Mishaela , Palermo Andrea , Gagnon Claudia , Tsourdi Elena , Zhao Carol , Makara Michael , Ominsky Michael , Lai Bryant , Ukena Jenny , Sibley Christopher , Shu Aimee

Hypoparathyroidism is an endocrine disease caused by insufficient levels of parathyroid hormone (PTH). Individuals with chronic hypoparathyroidism managed with conventional therapy (active vitamin D and calcium) are at increased risk for renal complications and declines in renal function. In clinical trials, palopegteriparatide treatment enabled independence from conventional therapy (no active vitamin D and ≤600 mg/day elemental calcium) and maintained serum biochemistr...

ea0051p095 | Diabetes | BSPED2017

The transition of care from paediatric to adult services in diabetes

Marguerie Rachel , Diskin Lynn , Vass Claire

Background: The transition from paediatric to adult care can be challenging for patients with Type 1 diabetes. Poor contiuity of care provided by the diabetes team may worsen an already difficult time for these patients. Good transition of care is vital to minimise the risk of worsening patient outcomes. In 2016, two patients failed to transition from paediatric to adult diabetes care and subsequently received no adult appointment. This breakdown of continuity of care was a re...

ea0007p122 | Endocrine tumours and neoplasia | BES2004

Retrospective audit of bilateral adrenalectomies with reference to the occurrence of Nelson's syndrome

Green A , Barakat M , Lynn J , Meeran K

ObjectiveTo assess the results of bilateral adrenalectomy and further assess the relevance of Nelson's syndrome as a complication of bilateral adrenalectomy.Patients33 patients treated by bilateral adrenalectomy at the Hammersmith Hospital were identified (earliest operation performed in 1958). Although all bilateral adrenalectomies in recent years were included, it was not possible to confirm that all bilate...

ea0078p29 | Diabetes | BSPED2021

Initial insulin dose and trend review for CYP with T1DM

Kyi Nway , Htar Shwe , Lynn Swe , Fountain-Polley Simon

Introduction: Recommended starting insulin doses in CYP with newly diagnosed type 1 diabetes vary widely from 0.3 to 1.0 U/kg/day. However, there is no study for rate of change of insulin dose in first few months of initiating insulin.Aim: Retrospective review of insulin total daily dose at diagnosis, hospital discharge, and at first clinic, documenting changes in % basal insulin with time, considering any impact of insulin treatment on body weight and H...

ea0075d19 | Diabetes | EYES2021

An usual case of hypoglycaemia

Coulden Amy , Ko Ye Lynn , Toogood Andrew , Ayuk John

A 69-year-old non-diabetic woman presented with 1 month of recurrent drowsiness and confusion secondary to hypoglycaemia, nocturnal and on fasting. On admission her CBG was 2.6 mmol/l, confirmed venously. Her history was of a large solitary fibrous tumour (SFT) of the chest wall first resected in 2011 with recurrent relapses requiring surgery in 2016 and 2017. Histology showed typical features of SFT. Despite palliative chemo-radiotherapy for a further relapses, there was prog...

ea0088009 | Abstracts | BES2022

The course and outcome of subacute thyroiditis: a retrospective analysis and predictive model

Filette Jeroen de , Mey Lynn De , Rop Jonas De , David Unuane , Kurt Barbe , Bert Bravenboer

Background: Subacute thyroiditis (SAT) is a destructive thyroiditis of probable viral origin. Thyroid dysfunction evolves through a set of stages (hyperthyroidism - hypothyroidism - euthyroidism) and is usually temporary, although some patients develop permanent hypothyroidism. The risk factors for permanent hypothyroidism remain largely unclear.Methods: A retrospective analysis of patients with SAT at the University Hospital of Brussels from 2001-2020 w...

ea0065p69 | Adrenal and Cardiovascular | SFEBES2019

Adrenal incidentaloma multi-disciplinary investigation and management at University Hospitals of Derby and Burton Foundation Trust

Morrison Amy , Ko Ye Lynn , Agha Adnan , Kirke Rathy , Sugunendran Suma , Hughes David

Introduction: Incidental indeterminate adrenal nodules discovered on imaging in patients under the care of University Hospitals of Derby and Burton Foundation Trust are discussed in Urology MDT. MDT cases were reviewed for a 12 month period before an endocrinologist joined the MDT in January 2018 and 12 months afterwards, to review the compliance of local practice with European Society of Endocrinology (ESE) Guidelines for the management of adrenal incidentalomas.<p class=...

ea0046p21 | (1) | UKINETS2016

Efficacy of the combination of Capecitabine and Temozolamide in patients with advanced Pulmonary Carcinoid Tumors: A single institution experience

Kordatou Zoe , Papaxoinis George , McCallum Lynn , Salih Zena , Nasralla Magdy , Nonaka Daisuke , Mansoor Wasat

Background: Pulmonary carcinoids (PC) are rare neuroendocrine tumors (NETs). The course of PCs is considered to be indolent, but patients with advanced disease have low survival rates and their treatment options are limited. As PCs are under-represented in trials, therapeutic decisions are based on evidence extrapolated from other types of NETS. Capecitabine-Temozolamide (CAPTEM) has demonstrated significant efficacy in pancreatic NETs. However, its role in PCs is still unexpl...

ea0013oc25 | Neuroendocrinology, reproduction and cardiovascular | SFEBES2007

Manipulation of proprotein convertase 1 expression in AtT20 cells changes proopiomelanocortin processing and trafficking: Implications for ACTH regulatory pathways

Day Tom , Warhurst Anne , Oliver Robert L , Pritchard Lynn E , White Anne

We have previously shown that the ACTH precursor, POMC, is present in human plasma and is the predominant secreted POMC peptide. This suggests that POMC processing is incomplete in neuroendocrine cells and regulation of the post-translational cleavage pathway is important in controlling secretion of ACTH. We have therefore analysed the dynamics of POMC processing in both AtT20 pituitary adenoma cells and primary rat pituitary cells. In both cases, large quantities of POMC, as ...